Mutation-Risk Predictive Oncology Tool

A clinical decision support tool that monitors changes in blood-based tumor mutational burden (bTMB)—the number of mutations in the tumor's DNA found in the blood—to identify early signs of drug resistance. It helps oncologists detect molecular progression via liquid biopsies before it becomes visible on medical imaging.